Literature DB >> 30580423

Cell-Free DNA Integrity: Applications.

Sara Ravaioli1.   

Abstract

Cell-free DNA integrity (cfDNAi) could be a valuable biomarker for solid tumors, to define prognosis and response to therapy. Several elements have been studied for cfDNAi, such as specific genes involved in cancer progression or repetitive DNA sequences as surrogate markers for the whole circulating DNA.However, the lack of a standardized method for cfDNAi evaluation remains one of its main critical issues. Apoptotic index (AI) and integrity index (II) of cfDNA could be useful biomarkers to identify the patients likely to recur, progress, or relapse, which is an urgent need in translational research in oncology.Here it is provided an adequate method of cfDNAi analysis: a cheap and reproducible tool, robust and performable in all laboratories using a real-time PCR instrument.

Entities:  

Keywords:  Apoptotic index; Biomarker; Integrity index; Real-time PCR; cfDNA integrity

Mesh:

Substances:

Year:  2019        PMID: 30580423     DOI: 10.1007/978-1-4939-8973-7_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma.

Authors:  Kun Ma; Jiayun Liu; Youjin Wang; Yubin Zhong; Zhenfeng Wu; Ruiying Fan; Shanfeng Guo
Journal:  J Gastrointest Oncol       Date:  2020-12

Review 2.  Cell-free DNA analysis in current cancer clinical trials: a review.

Authors:  M Cisneros-Villanueva; L Hidalgo-Pérez; M Rios-Romero; A Cedro-Tanda; C A Ruiz-Villavicencio; K Page; R Hastings; D Fernandez-Garcia; R Allsopp; M A Fonseca-Montaño; S Jimenez-Morales; V Padilla-Palma; J A Shaw; A Hidalgo-Miranda
Journal:  Br J Cancer       Date:  2022-01-13       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.